Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China: A Multicenter Post-Marketing Observational Study

NCT01074931 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01074931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01074931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China: A Multicenter Post-Marketing Observational Study
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
April 30, 2008
Completion date
June 30, 2010
Enrollment
98 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1 infections